80_FR_12545 80 FR 12500 - Advisory Committee on Infant Mortality; Notice of Meeting

80 FR 12500 - Advisory Committee on Infant Mortality; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 80, Issue 45 (March 9, 2015)

Page Range12500-12500
FR Document2015-05416

Federal Register, Volume 80 Issue 45 (Monday, March 9, 2015)
[Federal Register Volume 80, Number 45 (Monday, March 9, 2015)]
[Notices]
[Page 12500]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-05416]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Infant Mortality; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Committee on Infant Mortality (ACIM).
    Dates and Times:

March 26, 2015, 8:30 a.m.-5:30 p.m.
March 27, 2015, 8:30 a.m.-3:30 p.m.

    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Status: The meeting is open to the public with attendance limited 
to space availability. For more details and registration, please visit 
the ACIM Web site: http://www.hrsa.gov/advisorycommittees/mchbadvisory/InfantMortality/index.html.
    Purpose: The Committee provides advice and recommendations to the 
Secretary of Health and Human Services on the following: Department of 
Health and Human Services' programs that focus on reducing infant 
mortality and improving the health status of infants and pregnant 
women; and factors affecting the continuum of care with respect to 
maternal and child health care. The Committee focuses on outcomes 
following childbirth; strategies to coordinate myriad federal, state, 
local, and private programs and efforts that are designed to deal with 
the health and social problems impacting on infant mortality; and the 
implementation of the Healthy Start Program and Healthy People 2020 
infant mortality objectives.
    Agenda: Topics that will be discussed include the following: HRSA 
Update; MCHB Update; Healthy Start Program Update; Updates from 
Partnering Agencies and Organizations; and, ACIM's recommendations for 
the HHS National Strategy to Address Infant Mortality, specifically 
Strategy 4: Increase Health Equity and Reduce Disparities by Targeting 
Social Determinants of Health through both Investments in High-Risk, 
Under-Resourced Communities and Major Initiatives to Address Poverty. 
Proposed agenda items are subject to change as priorities dictate.
    Time will be provided for public comments limited to 5 minutes 
each. Comments are to be submitted in writing no later than 5:00 p.m. 
(EST) on March 19, 2015.

For Further Information Contact: Anyone requiring information regarding 
the Committee should contact Michael C. Lu, M.D., M.P.H., Executive 
Secretary, ACIM, Health Resources and Services Administration, Room 18 
W, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, 
telephone: (301) 443-2170.
    Individuals who are submitting public comments or who have 
questions regarding the meeting and location should contact David S. de 
la Cruz, Ph.D., M.P.H., ACIM Designated Federal Official, HRSA, 
Maternal and Child Health Bureau, telephone: (301) 443-0543, or email: 
[email protected].

Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015-05416 Filed 3-6-15; 8:45 am]
 BILLING CODE 4165-15-P



                                                  12500                          Federal Register / Vol. 80, No. 45 / Monday, March 9, 2015 / Notices

                                                  552b(c)(4) and 552b(c)(6), title 5 U.S.C.,              advisorycommittees/mchbadvisory/                      DEPARTMENT OF HEALTH AND
                                                  as amended. The grant applications and                  InfantMortality/index.html.                           HUMAN SERVICES
                                                  the discussions could disclose                             Purpose: The Committee provides
                                                  confidential trade secrets or commercial                                                                      Food and Drug Administration
                                                                                                          advice and recommendations to the
                                                  property such as patentable material,                   Secretary of Health and Human Services                [Docket No. FDA–2014–N–0913]
                                                  and personal information concerning                     on the following: Department of Health
                                                  individuals associated with the grant                   and Human Services’ programs that                     Agency Information Collection
                                                  applications, the disclosure of which                   focus on reducing infant mortality and                Activities; Submission for Office of
                                                  would constitute a clearly unwarranted                  improving the health status of infants                Management and Budget Review;
                                                  invasion of personal privacy.                           and pregnant women; and factors                       Comment Request; 513(g) Request for
                                                    Name of Committee: National Institute of              affecting the continuum of care with                  Information
                                                  Diabetes and Digestive and Kidney Diseases              respect to maternal and child health                  AGENCY:   Food and Drug Administration,
                                                  Special Emphasis Panel, Ancillary Study on              care. The Committee focuses on
                                                  IBD.
                                                                                                                                                                HHS.
                                                                                                          outcomes following childbirth;                        ACTION:   Notice.
                                                    Date: April 8, 2015.
                                                    Time: 4:30 p.m. to 6:00 p.m.                          strategies to coordinate myriad federal,
                                                    Agenda: To review and evaluate grant                  state, local, and private programs and                SUMMARY:   The Food and Drug
                                                  applications.                                           efforts that are designed to deal with the            Administration (FDA) is announcing
                                                    Place: National Institutes of Health, Two             health and social problems impacting                  that a proposed collection of
                                                  Democracy Plaza, 6707 Democracy                         on infant mortality; and the                          information has been submitted to the
                                                  Boulevard, Bethesda, MD 20892, (Telephone               implementation of the Healthy Start                   Office of Management and Budget
                                                  Conference Call).                                       Program and Healthy People 2020 infant                (OMB) for review and clearance under
                                                    Contact Person: Maria E. Davila-Bloom,                                                                      the Paperwork Reduction Act of 1995.
                                                                                                          mortality objectives.
                                                  Ph.D., Scientific Review Officer, Review
                                                                                                                                                                DATES: Fax written comments on the
                                                  Branch, DEA, NIDDK, National Institutes of                 Agenda: Topics that will be discussed
                                                  Health, Room 758, 6707 Democracy                        include the following: HRSA Update;                   collection of information by April 8,
                                                  Boulevard, Bethesda, MD 20892–5452, (301)               MCHB Update; Healthy Start Program                    2015.
                                                  594–7637, davila-bloomm@                                Update; Updates from Partnering                       ADDRESSES: To ensure that comments on
                                                  extra.niddk.nih.gov.                                    Agencies and Organizations; and,                      the information collection are received,
                                                  (Catalogue of Federal Domestic Assistance               ACIM’s recommendations for the HHS                    OMB recommends that written
                                                  Program Nos. 93.847, Diabetes,                          National Strategy to Address Infant                   comments be faxed to the Office of
                                                  Endocrinology and Metabolic Research;                                                                         Information and Regulatory Affairs,
                                                  93.848, Digestive Diseases and Nutrition                Mortality, specifically Strategy 4:
                                                  Research; 93.849, Kidney Diseases, Urology              Increase Health Equity and Reduce                     OMB, Attn: FDA Desk Officer, FAX:
                                                  and Hematology Research, National Institutes            Disparities by Targeting Social                       202–395–7285, or emailed to oira_
                                                  of Health, HHS)                                         Determinants of Health through both                   submission@omb.eop.gov. All
                                                                                                          Investments in High-Risk, Under-                      comments should be identified with the
                                                    Dated: March 3, 2015.
                                                                                                          Resourced Communities and Major                       OMB control number 0910–0705. Also
                                                  David Clary,                                                                                                  include the FDA docket number found
                                                                                                          Initiatives to Address Poverty. Proposed
                                                  Program Analyst, Office of Federal Advisory                                                                   in brackets in the heading of this
                                                  Committee Policy.
                                                                                                          agenda items are subject to change as
                                                                                                          priorities dictate.                                   document.
                                                  [FR Doc. 2015–05311 Filed 3–6–15; 8:45 am]
                                                                                                             Time will be provided for public                   FOR FURTHER INFORMATION CONTACT: FDA
                                                  BILLING CODE 4140–01–P
                                                                                                          comments limited to 5 minutes each.                   PRA Staff, Office of Operations, Food
                                                                                                          Comments are to be submitted in                       and Drug Administration, 8455
                                                  DEPARTMENT OF HEALTH AND                                writing no later than 5:00 p.m. (EST) on              Colesville Rd., COLE–14526, Silver
                                                  HUMAN SERVICES                                          March 19, 2015.                                       Spring, MD 20993–0002, PRAStaff@
                                                                                                                                                                fda.hhs.gov.
                                                                                                          FOR FURTHER INFORMATION CONTACT:
                                                  Health Resources and Services                                                                                 SUPPLEMENTARY INFORMATION: In
                                                  Administration                                          Anyone requiring information regarding
                                                                                                          the Committee should contact Michael                  compliance with 44 U.S.C. 3507, FDA
                                                                                                          C. Lu, M.D., M.P.H., Executive                        has submitted the following proposed
                                                  Advisory Committee on Infant                                                                                  collection of information to OMB for
                                                  Mortality; Notice of Meeting                            Secretary, ACIM, Health Resources and
                                                                                                          Services Administration, Room 18 W,                   review and clearance.
                                                     In accordance with section 10(a)(2) of               Parklawn Building, 5600 Fishers Lane,                 513(g) Request for Information—(OMB
                                                  the Federal Advisory Committee Act                      Rockville, Maryland 20857, telephone:                 Control Number 0910–0705)—
                                                  (Pub. L. 92–463), notice is hereby given                (301) 443–2170.                                       (Extension)
                                                  of the following meeting:
                                                                                                            Individuals who are submitting public                 Section 513(g) of the Federal Food,
                                                     Name: Advisory Committee on Infant
                                                                                                          comments or who have questions                        Drug, and Cosmetic Act (the FD&C Act)
                                                  Mortality (ACIM).
                                                                                                          regarding the meeting and location                    (21 U.S.C. 360c(g)) provides a means for
                                                     Dates and Times:                                     should contact David S. de la Cruz,                   obtaining the Agency’s views about the
                                                  March 26, 2015, 8:30 a.m.–5:30 p.m.                     Ph.D., M.P.H., ACIM Designated Federal                classification and regulatory
                                                  March 27, 2015, 8:30 a.m.–3:30 p.m.                     Official, HRSA, Maternal and Child                    requirements that may be applicable to
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                     Place: Hyatt Regency Bethesda, One                   Health Bureau, telephone: (301) 443–                  a particular device. Section 513(g)
                                                  Bethesda Metro Center, 7400 Wisconsin                   0543, or email: David.delaCruz@                       provides that, within 60 days of the
                                                  Avenue, Bethesda, MD 20814.                             hrsa.hhs.gov.                                         receipt of a written request of any
                                                     Status: The meeting is open to the                                                                         person for information respecting the
                                                                                                          Jackie Painter,
                                                  public with attendance limited to space                                                                       class in which a device has been
                                                  availability. For more details and                      Director, Division of the Executive Secretariat.      classified or the requirements applicable
                                                  registration, please visit the ACIM Web                 [FR Doc. 2015–05416 Filed 3–6–15; 8:45 am]            to a device under the FD&C Act, the
                                                  site: http://www.hrsa.gov/                              BILLING CODE 4165–15–P                                Secretary of Health and Human Services


                                             VerDate Sep<11>2014   18:04 Mar 06, 2015   Jkt 235001   PO 00000   Frm 00079   Fmt 4703   Sfmt 4703   E:\FR\FM\09MRN1.SGM   09MRN1



Document Created: 2015-12-18 12:05:51
Document Modified: 2015-12-18 12:05:51
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ContactAnyone requiring information regarding the Committee should contact Michael C. Lu, M.D., M.P.H., Executive Secretary, ACIM, Health Resources and Services Administration, Room 18 W, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, telephone: (301) 443-2170.
FR Citation80 FR 12500 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR